Skip to main content
Fig. 2 | Cost Effectiveness and Resource Allocation

Fig. 2

From: Cost-effectiveness evaluation of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine for children in Taiwan

Fig. 2

One-way sensitivity analyses tornado plot for PHiD-CV vs. PCV13. AOM: acute otitis media; GP: general practitioner; PCV13: 13-valent pneumococcal conjugate vaccine; PHiD-CV: 10-valent pneumococcal polysaccharide and NTHi protein D conjugate vaccine; NT$: new Taiwan dollar; QALY: quality adjusted life year Sp: Streptococcus pneumoniae; VT: vaccine type

Back to article page
\